Karyopharm and Menarini Group Receive Full Marketing Authorisa...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
NEWTON, Mass. and FLORENCE, Italy, July 21, 2022 /PRNewswire-AsiaNet/ -- – Based on Results from Phase 3 BOSTON Study, Marketing Authorisation Expands Multiple Myeloma Indication –– Approval Follows Positive Opinion by European Committee for Medicinal Products for Human Use (CHMP) in May 2022 –Karyopharm Therap...
Authors: LATEST ASIANET NEWS RELEASES